# EEPD1 evolved a unique DNA clamping dimer protecting reversed replication forks

**Authors:** Runze Shen, Altaf H Sarker, Yue Chen, Min Liu, Sunetra Roy, Andrew S Arvai, Albino Bacolla, Zamal Ahmed, Panagiotis Katsonis, Michal Hammel, Isao Kuraoka, Miaw-Sheue Tsai, Corydon Irie, Lukas Webb, Olivier Lichtarge, Chi-Lin Tsai, Susan E Tsutakawa, Katharina Schlacher, John A Tainer

PMC · DOI: 10.1093/nar/gkag188 · Nucleic Acids Research · 2026-03-14

## TL;DR

This study reveals that EEPD1 protects DNA replication forks by clamping them, not cutting them, which helps maintain genome stability and affects cancer outcomes.

## Contribution

The paper discovers EEPD1's unique DNA clamping dimer function in protecting reversed replication forks, challenging its proposed nuclease role.

## Key findings

- EEPD1 uses a dimeric EEP domain and (HhH)2 domains to clamp DNA at reversed replication forks.
- EEPD1 lacks nuclease activity due to loss of catalytic residues during evolution but prevents MRE11-mediated degradation.
- Cancer data show EEPD1's role in oxidative stress responses correlates with patient survival.

## Abstract

Exonuclease/endonuclease/phosphatase (EEP)-fold hydrolases are canonically monomeric phosphodiesterases exemplified by APE1, DNase I, and TDP2 nucleases. While EEP family domain containing protein 1 (EEPD1) acts in DNA stress responses, its proposed nuclease activities are enigmatic. Here, we integrate hybrid structural methods, evolution, biochemistry, cancer genomics, plus molecular and cell biology to define EEPD1 structure, assembly, and function at stalled DNA replication forks. Results imply EEPD1 surprisingly requires both unique EEP domain dimer and distinctive tandem Helix-hairpin-Helix [(HhH)2] domains to clamp double-stranded (ds) DNA at reversed DNA replication forks for fork protection. Small-angle X-ray Scattering (SAXS), crystal, and cryo-EM structures unveil an unprecedented tryptophan handshake dimer, conserved interface di-Trp-Pro pocket, and adjustable “wrist” enabling an open-closed conformational switch. EEPD1 dimer cooperatively binds complex dsDNA replication fork intermediates but alone lacks nuclease activity due to loss of key EEP catalytic residues during Metazoan evolution and atmospheric oxygen buildup. Instead, EEPD1 prevents nucleolytic degradation of reversed replication forks by MRE11. Furthermore, cancer bioinformatics support oxidative damage-dependent EEPD1 association as a significant modulator of overall patient survival. Collective findings uncover unexpected EEP dimer and fork protection function in clamping, not cleaving, reversed replication forks for metazoan oxidative stress responses controlling genome stability and cancer outcomes.

Graphical Abstract

## Linked entities

- **Genes:** EEPD1 (endonuclease/exonuclease/phosphatase family domain containing 1) [NCBI Gene 80820], APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328], Dnase1 (deoxyribonuclease I) [NCBI Gene 13419], TDP2 (tyrosyl-DNA phosphodiesterase 2) [NCBI Gene 51567], MRE11 (MRE11 double strand break repair nuclease) [NCBI Gene 4361]
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, SMARCAL1 (SNF2 related chromatin remodeling annealing helicase 1) [NCBI Gene 50485] {aka HARP, HHARP}, IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, EME1 (essential meiotic structure-specific endonuclease 1) [NCBI Gene 146956] {aka MMS4L, SLX2A}, EXO1 (exonuclease 1) [NCBI Gene 9156] {aka HEX1, hExoI}, SMPD2 (sphingomyelin phosphodiesterase 2) [NCBI Gene 6610] {aka ISC1, NSMASE, NSMASE1}, MRE11 (MRE11 double strand break repair nuclease) [NCBI Gene 4361] {aka ATLD, HNGS1, MRE11A, MRE11B}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, GADD45A (growth arrest and DNA damage inducible alpha) [NCBI Gene 1647] {aka DDIT1, GADD45}, NEIL1 (nei like DNA glycosylase 1) [NCBI Gene 79661] {aka FPG1, NEI1, hFPG1}, POLB (DNA polymerase beta) [NCBI Gene 5423], AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}, MFSD11 (major facilitator superfamily domain containing 11) [NCBI Gene 79157] {aka ET}, MUS81 (MUS81 structure-specific endonuclease subunit) [NCBI Gene 80198] {aka SLX3}, MAP3K10 (mitogen-activated protein kinase kinase kinase 10) [NCBI Gene 4294] {aka MEKK10, MLK2, MST}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, INPP5J (inositol polyphosphate-5-phosphatase J) [NCBI Gene 27124] {aka INPP5, PIB5PA, PIPP}, ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit) [NCBI Gene 2067] {aka COFS4, RAD10, UV20}, ZRANB3 (zinc finger RANBP2-type containing 3) [NCBI Gene 84083] {aka 4933425L19Rik, AH2}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, EEPD1 (endonuclease/exonuclease/phosphatase family domain containing 1) [NCBI Gene 80820] {aka HSPC107}, FANCD2 (FA complementation group D2) [NCBI Gene 2177] {aka FA-D2, FA4, FACD, FAD, FAD2, FANCD}, FANCI (FA complementation group I) [NCBI Gene 55215] {aka KIAA1794}, XRCC1 (X-ray repair cross complementing 1) [NCBI Gene 7515] {aka RCC, SCAR26}, TCEA2 (transcription elongation factor A2) [NCBI Gene 6919] {aka TFIIS}, UNG (uracil DNA glycosylase) [NCBI Gene 7374] {aka DGU, HIGM4, HIGM5, UDG, UNG1, UNG15}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, SLFN5 (schlafen family member 5) [NCBI Gene 162394], SENP3 (SUMO specific peptidase 3) [NCBI Gene 26168] {aka SMT3IP1, SSP3, Ulp1}, FAN1 (FANCD2 and FANCI associated nuclease 1) [NCBI Gene 22909] {aka KIAA1018, KMIN, MTMR15, hFAN1}, IGKV5-2 (immunoglobulin kappa variable 5-2) [NCBI Gene 28907] {aka B2, IGKV52}, SLFN11 (schlafen family member 11) [NCBI Gene 91607] {aka SLFN8/9}, RPA1 (replication protein A1) [NCBI Gene 6117] {aka HSSB, MST075, PFBMFT6, REPA1, RF-A, RP-A}, TDP2 (tyrosyl-DNA phosphodiesterase 2) [NCBI Gene 51567] {aka AD022, EAP2, EAPII, TTRAP, dJ30M3.3, hTDP2}, RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}, SLC25A15 (solute carrier family 25 member 15) [NCBI Gene 10166] {aka D13S327, HHH, LNC-HC, ORC1, ORNT1}, FEN1 (flap structure-specific endonuclease 1) [NCBI Gene 2237] {aka FEN-1, MF1, RAD2}, OGG1 (8-oxoguanine DNA glycosylase) [NCBI Gene 4968] {aka HMMH, HOGG1, MUTM, OGH1}, DNASE1 (deoxyribonuclease 1) [NCBI Gene 1773] {aka DNL1, DRNI}, CCR4 (C-C motif chemokine receptor 4) [NCBI Gene 1233] {aka CC-CKR-4, CD194, CKR4, CMKBR4, ChemR13, HGCN:14099}, HLTF (helicase like transcription factor) [NCBI Gene 6596] {aka HIP116, HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3}, ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit) [NCBI Gene 2072] {aka ERCC11, FANCQ, RAD1, XFEPS, XPF}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}
- **Diseases:** EEP (MESH:C562645), colorectal, breast, brain, and prostate (MESH:D011472), esophageal cancer (MESH:D004938), kidney, colon, prostate, and liver cancers (MESH:D011471), oncogenesis (MESH:D063646), UVM (MESH:C536494), thyroid, breast, and lung cancers (MESH:D001943), GBM (MESH:D005909), Cancer (MESH:D009369), LGG (MESH:D005910)
- **Chemicals:** d-biotin (MESH:D001710), Alexa Fluor 555 (MESH:C000608607), glycerol (MESH:D005990), EDTA (MESH:D004492), HEPES (MESH:D006531), lipid (MESH:D008055), BIS (MESH:D001729), TCEP (MESH:C080938), Trp (MESH:D014364), MgCl2 (MESH:D015636), SDS (MESH:D012967), BS3 (MESH:C035760), bromophenol blue (MESH:D001978), Heparin (MESH:D006493), sodium phosphate (MESH:C018279), acetic acid (MESH:D019342), imidazole (MESH:C029899), NP-40 (MESH:C010615), oxygen (MESH:D010100), Triton X (MESH:D017830), acids (MESH:D000143), KCl (MESH:D011189), PMSF (MESH:D010664), EdU (MESH:C022811), H (MESH:D006859), 5-iodo-2'-deoxyuridine (-), cholesterol (MESH:D002784), Gly (MESH:D005998), polyacrylamide (MESH:C016679), water (MESH:D014867), DTT (MESH:D004229), IdU (MESH:D007065), silica (MESH:D012822), butyrate (MESH:D002087), nitrogen (MESH:D009584), Urea (MESH:D014508), prolines (MESH:D011392), guanine (MESH:D006147), NaCl (MESH:D012965), MES (MESH:C004550), THF (MESH:C018674), BrdU (MESH:D001973), Asp (MESH:D001224), CPT (MESH:D002166), 5-chloro-2'-deoxyuridine (MESH:C012244), HU (MESH:D006918), formamide (MESH:C031066), HCl (MESH:D006851), xylene cyanol (MESH:C048951), amine (MESH:D000588), metal (MESH:D008670), His (MESH:D006639), uracil (MESH:D014498), sodium bicarbonate (MESH:D017693), Tween-20 (MESH:D011136), CO2 (MESH:D002245), desthiobiotin (MESH:C004749), methanol (MESH:D000432), H2O2 (MESH:D006861), Glu (MESH:D018698)
- **Species:** Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090], Rhodophyta (red algae, phylum) [taxon 2763], Alvinella pompejana (species) [taxon 6376], Gracilariopsis (genus) [taxon 2781]
- **Mutations:** K275E, W522A, Asp210, Tyr171 in place of His, Asp-Asn, H404A, His404, Asn with Gly, G526W, D210N, Asn212, N212A, S523P
- **Cell lines:** 3KO — Homo sapiens (Human), Transformed cell line (CVCL_HB82), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), Expi293F — Homo sapiens (Human), Transformed cell line (CVCL_D615)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12988330/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12988330/full.md

## References

140 references — full list in the complete paper: https://tomesphere.com/paper/PMC12988330/full.md

---
Source: https://tomesphere.com/paper/PMC12988330